Adagio Medical Holdings, Inc. 8-K

What Happened

• On March 26, 2026, Adagio Medical Holdings, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025 via a press release. The company furnished that press release as Exhibit 99.1 to an 8‑K (Item 2.02) and incorporated it by reference. The filing was signed by Deborah Kaster, Chief Financial Officer and Chief Business Officer.

Key Details

• Event reported: Item 2.02 — Results of Operations and Financial Condition (press release filed).
• Press release date: March 26, 2026 (filed as Exhibit 99.1).
• Reporting period: Fourth quarter and fiscal year ended December 31, 2025.
• Signed by: Deborah Kaster, CFO & Chief Business Officer, dated March 26, 2026.

Why It Matters

• This 8‑K notifies investors that Adagio has released its quarterly and full‑year earnings and a business update; the press release (Exhibit 99.1) will contain the specific earnings, revenue, and operational details investors care about.
• Retail investors should review the furnished press release for the company’s reported results and any commentary on performance or outlook, and watch for related filings (e.g., Form 10‑K or subsequent earnings materials) for audited numbers and more detail.